Published in Circulation on June 10, 2008
Associations of cardiovascular disease risk factors and calcified atherosclerosis with aortoiliac bifurcation position: the MultiEthnic Study of Atherosclerosis. Angiology (2013) 1.46
Isolated idiopathic aortitis with an unusually thickened aortic wall: case report. Ann Transl Med (2016) 1.38
Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol (2010) 1.29
Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther (2011) 1.12
Insights into imaging of aortitis. Insights Imaging (2012) 1.08
The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? Biomed Res Int (2014) 1.01
Pathology of Takayasu arteritis: A brief review. Ann Pediatr Cardiol (2013) 0.97
Luetic aortopathy: Revisited. Indian J Sex Transm Dis (2010) 0.91
Septic rupture of an atherosclerotic plaque of the ascending aorta. Interact Cardiovasc Thorac Surg (2012) 0.88
Bartonella quintana Aortitis in a Man with AIDS, Diagnosed by Needle Biopsy and 16S rRNA Gene Amplification. J Clin Microbiol (2015) 0.88
Early diagnosis of nonaneurysmal infectious thoracic aortitis using transesophageal echocardiogram in a patient with purulent meningitis. Cardiol Res Pract (2010) 0.87
Radiological features of uncommon aneurysms of the cardiovascular system. World J Radiol (2016) 0.85
Acute Conditions Caused by Infectious Aortitis. Aorta (Stamford) (2014) 0.83
Takayasu's arteritis: Is it a reversible disease? Case Report and Literature Review. Surg Neurol Int (2012) 0.81
Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. Clin Rheumatol (2012) 0.81
[Magnetic resonance angiography in rheumatology]. Z Rheumatol (2012) 0.80
Mycotic abdominal aortic aneurysm caused by bacteroides thetaiotaomicron and acinetobacter lwoffii: the first case in Korea. Infect Chemother (2014) 0.80
Aortic intimal fold in Takayasu arteritis causing obstruction of left coronary ostium. Pediatr Cardiol (2011) 0.79
Perfusion-based assessment of disease activity in untreated and treated patients with aortitis and chronic periaortitis: correlation with CT morphological, clinical and serological data. Br J Radiol (2015) 0.78
Evaluation of the intraoperative specimens of the thoracic and abdominal aorta. J Cardiothorac Surg (2013) 0.77
Thoracic endovascular aortic repair as emergency therapy despite suspected aortic infection. Interact Cardiovasc Thorac Surg (2013) 0.77
Ascending aortic aneurysm caused by Mycobacterium tuberculosis. BMC Res Notes (2015) 0.76
Multidetector CT evaluation of various aortic diseases: diagnostic tips, pitfalls, and remedies for imaging artifacts. Int J Cardiovasc Imaging (2012) 0.75
Aortitis requiring aortic repair associated with glaucoma, thyroiditis, glaucoma, and neuropathy: case report. J Cardiothorac Surg (2011) 0.75
Inflammatory diseases of the aorta: Part 1: Non-infectious aortitis. Gefasschirurgie (2016) 0.75
Chest CT examinations in patients presenting with acute chest pain: a pictorial review. Insights Imaging (2015) 0.75
Anemia in a middle aged female with aortitis: a case report. BMC Res Notes (2015) 0.75
Pleural Empyema and Aortic Aneurysm: A Retrospective National Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.75
A case of idiopathic aortitis mimicking severe aortic stenosis. J Cardiovasc Ultrasound (2010) 0.75
A Rare Cause of Primary Aortoenteric Fistula: Streptococcus parasanguinis Aortitis. Case Rep Gastrointest Med (2017) 0.75
Coronary ostial stenosis and aortic aneurysm caused by syphilis. CMAJ (2017) 0.75
Takayasu's arteritis and an elevated antistreptolysin O titre - a potentially expensive diagnostic conundrum. JRSM Open (2014) 0.75
Infrarenal Infected Aortic Aneurysm Caused by Streptococcus pyogenes. Case Rep Surg (2017) 0.75
Inflammatory diseases of the aorta: Part 2: Infectious aortitis. Gefasschirurgie (2016) 0.75
A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia. Case Rep Hematol (2017) 0.75
Hemodynamic Correlates of Abnormal Aortic Root Dimension in an Adult Population: The Strong Heart Study. J Am Heart Assoc (2015) 0.75
Abdominal aortitis on PET CT: A case report and review of the literature. Int J Surg Case Rep (2015) 0.75
Infected abdominal aortic aneurysm caused by Streptococcus pneumoniae diagnosed using polymerase chain reaction. Surg Case Rep (2015) 0.75
Infective abdominal aortitis due to Campylobacter fetus bacteremia: A case report and review of literature. Intractable Rare Dis Res (2016) 0.75
Stanford type A aortic dissection secondary to infectious aortitis: a case report. J Korean Med Sci (2013) 0.75
Staphylococcal thoracic aortitis complicated by aortic dissection. World J Emerg Med (2013) 0.75
Cross-sectional imaging of aortic infections. Insights Imaging (2016) 0.75
Stanford type A aortic dissection after urgent prosthetic valve replacement: case reports. J Cardiothorac Surg (2014) 0.75
Deadly case of Pasteurella multocida aortitis and mycotic aneurysm following a cat bite. World J Clin Cases (2016) 0.75
Axillobifemoral Bypass for Aortitis Syndrome in a Living-Donor Liver Transplant Patient. Ann Vasc Dis (2016) 0.75
Pulmonary oedema in the emergency room: what is hidden beyond an apparently common presentation. BMJ Case Rep (2014) 0.75
Isolated necrotizing aortitis presenting as incidental thoracoabdominal aortic aneurysm: a case report. Int J Angiol (2011) 0.75
Abdominal pain may dominate the scene of idiopathic aortitis. Rheumatol Int (2009) 0.75
A case report of CT-diagnosed renal infarct secondary to syphilitic aortitis. BMC Infect Dis (2017) 0.75
Core curriculum illustration: infectious aortitis. Emerg Radiol (2014) 0.75
Isolated aortitis: a rare cause of febrile illness. BMJ Case Rep (2015) 0.75
Contrast-enhanced magnetic resonance imaging to detect chronic aortic dissection complicated by acute aortitis. Radiol Case Rep (2017) 0.75
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
Behçet's disease. N Engl J Med (1999) 7.74
Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med (2002) 7.05
Takayasu arteritis. Ann Intern Med (1994) 5.94
Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med (1997) 4.51
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg (2001) 3.78
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum (2006) 3.64
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther (2005) 3.05
Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) (1985) 2.78
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 2.69
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum (2003) 2.64
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 2.62
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum (2001) 2.59
Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum (2007) 2.38
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum (2004) 2.32
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) (1980) 2.26
Chronic periaortitis. Rheumatology (Oxford) (2004) 2.12
Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med (1995) 2.02
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum (1994) 2.00
Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol (1992) 1.96
Management of infected aortoiliac aneurysms. Arch Surg (1991) 1.92
Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging (2003) 1.89
Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum (1991) 1.80
Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis. Eur Radiol (2002) 1.76
Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med (2005) 1.70
Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis (1999) 1.70
Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol (2005) 1.69
Concurrence of sarcoidosis and aortitis: case report and review of the literature. Ann Rheum Dis (2000) 1.57
Infectious Aortitis. Curr Treat Options Cardiovasc Med (2005) 1.57
Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation (2003) 1.56
Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum (2002) 1.56
Inflammatory abdominal aortic aneurysm. JAMA (2007) 1.52
Takayasu arteritis in Japan. Heart Vessels Suppl (1992) 1.52
Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol (2004) 1.51
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis (2001) 1.50
Mycotic aneurysms of the thoracic aorta: repair with use of endovascular stent-grafts. J Vasc Interv Radiol (1998) 1.50
Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol (2004) 1.50
The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging (2005) 1.47
The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging (2004) 1.45
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum (2004) 1.45
Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum (2000) 1.43
Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol (2006) 1.42
Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum (2005) 1.36
Incidence of aneurysms in Takayasu's arteritis. Angiology (1991) 1.36
Ankylosing spondylitis--cardiac manifestations. Clin Exp Rheumatol (2002) 1.33
Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum (2003) 1.31
Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg (2005) 1.29
The incidence and patterns of pulmonary artery involvement in Takayasu's arteritis. Clin Radiol (1990) 1.29
Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford) (2005) 1.28
Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol (2005) 1.28
Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol (2000) 1.28
HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum (1992) 1.27
Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol (1998) 1.24
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med (1975) 1.23
The management of mycotic aortic aneurysms: is there a role for endoluminal treatment? Acta Chir Belg (2006) 1.22
Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: "macaroni sign" as an indicator of the disease. Ultrasound Med Biol (1991) 1.22
Epidemiology of systemic vasculitis. Curr Rheumatol Rep (2005) 1.17
Takayasu's arteritis: vascular interventions and outcomes. J Rheumatol (2004) 1.16
A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn (1997) 1.15
Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology (2006) 1.14
A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol (2001) 1.13
The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) (2004) 1.13
Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2005) 1.12
Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology (2005) 1.10
Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation (2003) 1.09
The management of infected arterial aneurysms. J Cardiovasc Surg (Torino) (1977) 1.08
Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol (2003) 1.07
Salmonella aortitis. A report of a successfully treated case with a comprehensive review of the literature. Arch Intern Med (1993) 1.06
Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol (1994) 1.02
Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. N Engl J Med (1982) 1.02
Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol (2004) 1.01
Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol (1994) 1.01
Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol (2001) 1.01
Acceptable short-term results after endovascular repair of diseases of the thoracic aorta in high risk patients. Eur J Cardiothorac Surg (2003) 1.00
Diagnosis and management of stenotic aorto-arteriopathy in childhood. J Pediatr (1998) 0.99
Tuberculous aortoarteritis. Clin Radiol (1981) 0.99
Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol (2007) 0.96
Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am (2006) 0.95
Isolated pulmonary Takayasu arteritis: clinicopathologic characteristics. Mod Pathol (1996) 0.94
Aortic aneurysms in patients with Takayasu's arteritis: CT evaluation. AJR Am J Roentgenol (2000) 0.94
Steroid management in giant cell arteritis. Br J Ophthalmol (2001) 0.94
Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg (2006) 0.94
Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke (1996) 0.93
Stent supported angioplasty in Takayasu arteritis. Int J Cardiol (1998) 0.92
Non-atherosclerotic aorto-arterial thrombosis: A study of 30 cases at autopsy. J Postgrad Med (2001) 0.92
Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis (2006) 0.92
Aortitis and aortic thrombus in systemic lupus erythematosus. Lupus (2006) 0.91
Aortitis with dissection complicating systemic lupus erythematosus. Pathology (1995) 0.91
The utility of color duplex ultrasonography in the diagnosis of temporal arteritis. J Vasc Surg (2002) 0.90
Images in cardiovascular medicine. Implantation of a drug-eluting stent for the coronary artery stenosis of Takayasu arteritis: de novo and in-stent restenosis. Circulation (2006) 0.90
Endoluminal repair of mycotic thoracic aneurysms. J Endovasc Ther (2003) 0.90
Echocardiographic follow-up of patients with Takayasu's arteritis: five-year survival. Echocardiography (2006) 0.90
Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg (2005) 0.90
Technology Insight: the role of color and power Doppler ultrasonography in rheumatology. Nat Clin Pract Rheumatol (2007) 0.90
Carotid intima-medial thickness as a marker of disease activity in Takayasu's arteritis. Int J Cardiol (2005) 0.88
Behçet's aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr (2004) 0.88
The clinical application of 'edema-weighted' magnetic resonance imaging in the assessment of Takayasu's arteritis. Int J Cardiol (1998) 0.86
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985) (2006) 3.07
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation (2007) 2.63
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol (2008) 2.46
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 2.40
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res (2002) 2.37
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation (2003) 2.28
Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol (2007) 2.27
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg (2006) 2.14
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 2.02
Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med (2008) 1.98
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation (2003) 1.93
Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation (2005) 1.87
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res (2006) 1.84
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke (2011) 1.83
Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J (2009) 1.80
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 1.80
The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation (2006) 1.76
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 1.58
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol (2005) 1.56
Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation (2011) 1.51
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg (2015) 1.42
ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation (2005) 1.40
Thromboangiitis obliterans. Circulation (2010) 1.35
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation (2008) 1.34
Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation (2008) 1.28
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol (2003) 1.20
Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. J Vasc Surg (2006) 1.19
Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis (2008) 1.19
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J (2013) 1.17
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis (2008) 1.16
Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail (2009) 1.13
Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50. Circulation (2013) 1.13
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes Care (2013) 1.10
Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation (2009) 1.08
Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res (2004) 1.05
Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med (2011) 1.02
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. Eur Heart J (2012) 1.02
Acute effects of dietary glycemic index on antioxidant capacity in a nutrient-controlled feeding study. Obesity (Silver Spring) (2009) 1.02
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol (2004) 1.01
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg (2008) 1.01
Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol (2006) 1.00
Arginine and endothelial and vascular health. J Nutr (2004) 1.00
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med (2010) 0.99